The drugmaker has been seeking to bolster its pipeline as its top-selling drug, Keytruda, is set to lose patent protection.
Source link
Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns
Date:
Date:
The drugmaker has been seeking to bolster its pipeline as its top-selling drug, Keytruda, is set to lose patent protection.
Source link